Although there was no significant difference between the average CR1/CR3 values for serum samples from normal female donors versus breast cancer patients, possibly due to the small sample size, we do demonstrate the ability of our reagents to detect soluble CR1/CR3 in biological fluids. Here, CRIPTO3 is linked to breast cancer.